Overview
Medtronic plc is a globally recognized medical device company based in Dublin, Ireland. It primarily operates in the healthcare sector, focusing on the development, manufacturing, and sales of device-based medical therapies. Its diversified product portfolio addresses a wide range of chronic diseases including cardiac and vascular diseases, respiratory, neurological, and spinal conditions, among others. Medtronic is particularly noted for its contributions to diabetes management, heart therapies, and minimally invasive therapies. The company undertakes significant research and development efforts, evident from its robust pipeline of innovative medical technologies aimed at improving patient outcomes and expanding global access to healthcare. Medtronic's strategic projects often involve collaborations with health professionals and institutions to advance medical science and the application of technology in medicine.
Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Medtronic plc as of 25 July 2025 is 34,200.00 MM.
- The operating income for Medtronic plc as of 25 July 2025 is 6,560.00 MM.
- The net income for Medtronic plc as of 25 July 2025 is 4,660.00 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-07-25 | 34,200.00 | 6,560.00 | 4,660.00 |
| 2025-04-25 | 33,537.00 | 6,403.00 | 4,662.00 |
| 2025-01-24 | 33,199.00 | 6,744.00 | 4,260.00 |
| 2024-10-25 | 32,996.00 | 6,458.00 | 4,288.00 |
| 2024-07-26 | 32,577.00 | 6,373.00 | 3,927.00 |
| 2024-04-26 | 32,364.00 | 6,460.00 | 3,676.00 |
| 2024-01-26 | 32,320.00 | 6,343.00 | 4,201.00 |
| 2023-10-27 | 31,958.00 | 6,086.00 | 4,102.00 |
| 2023-07-28 | 31,558.00 | 6,026.00 | 3,620.00 |
| 2023-04-28 | 31,227.00 | 5,679.00 | 3,758.00 |
| 2023-01-27 | 30,771.00 | 5,823.00 | 4,064.00 |
| 2022-10-28 | 30,806.00 | 6,189.00 | 4,321.00 |
| 2022-07-29 | 31,070.00 | 6,301.00 | 5,205.00 |
| 2022-04-29 | 31,686.00 | 6,862.00 | 5,039.00 |
| 2022-01-28 | 31,785.00 | 6,910.00 | 4,914.00 |
| 2021-10-29 | 31,798.00 | 6,976.00 | 4,704.00 |
| 2021-07-30 | 31,597.00 | 6,502.00 | 3,882.00 |
| 2021-04-30 | 30,117.00 | 5,490.00 | 3,606.00 |
| 2021-01-29 | 27,926.00 | 3,895.00 | 2,892.00 |
| 2020-10-30 | 27,868.00 | 3,967.00 | 3,537.00 |
Income Statement: EPS
- The earnings per share basic for Medtronic plc as of 25 July 2025 is 3.63.
- The earnings per share diluted for Medtronic plc as of 25 July 2025 is 3.62.
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-07-25 | 3.63 | 3.62 |
| 2025-04-25 | 3.63 | 3.61 |
| 2025-01-24 | 3.29 | 3.28 |
| 2024-10-25 | 3.28 | 3.27 |
| 2024-07-26 | 2.98 | 2.97 |
| 2024-04-26 | 2.77 | 2.76 |
| 2024-01-26 | 3.16 | 3.15 |
| 2023-10-27 | 3.08 | 3.08 |
| 2023-07-28 | 2.72 | 2.71 |
| 2023-04-28 | 2.83 | 2.82 |
| 2023-01-27 | 3.05 | 3.04 |
| 2022-10-28 | 3.24 | 3.23 |
| 2022-07-29 | 3.89 | 3.87 |
| 2022-04-29 | 3.75 | 3.73 |
| 2022-01-28 | 3.65 | 3.63 |
| 2021-10-29 | 3.50 | 3.47 |
| 2021-07-30 | 2.89 | 2.86 |
| 2021-04-30 | 2.68 | 2.66 |
| 2021-01-29 | 2.15 | 2.13 |
| 2020-10-30 | 2.64 | 2.61 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Medtronic plc as of 25 July 2025 is 7,146.00 MM.
- The cash from investing activities for Medtronic plc as of 25 July 2025 is -2,397.00 MM.
- The cash from financing activities for Medtronic plc as of 25 July 2025 is -5,011.00 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-07-25 | 7,146.00 | -2,397.00 | -5,011.00 |
| 2025-04-25 | 7,044.00 | -1,937.00 | -4,361.00 |
| 2025-01-24 | 7,293.00 | -2,143.00 | -5,377.00 |
| 2024-10-25 | 7,195.00 | -2,007.00 | -5,124.00 |
| 2024-07-26 | 6,898.00 | -2,086.00 | -4,680.00 |
| 2024-04-26 | 6,787.00 | -2,366.00 | -4,450.00 |
| 2024-01-26 | 6,470.00 | -2,145.00 | -6,981.00 |
| 2023-10-27 | 5,570.00 | -1,725.00 | -7,615.00 |
| 2023-07-28 | 5,831.00 | -2,447.00 | -4,511.00 |
| 2023-04-28 | 6,039.00 | -3,493.00 | -4,960.00 |
| 2023-01-27 | 5,636.00 | -2,747.00 | -2,019.00 |
| 2022-10-28 | 6,290.00 | -2,897.00 | -1,062.00 |
| 2022-07-29 | 7,137.00 | -2,460.00 | -5,231.00 |
| 2022-04-29 | 7,346.00 | -1,659.00 | -5,336.00 |
| 2022-01-28 | 7,034.00 | -11.00 | -8,516.00 |
| 2021-10-29 | 7,162.00 | -2,347.00 | -8,337.00 |
| 2021-07-30 | 7,254.00 | -3,658.00 | -7,150.00 |
| 2021-04-30 | 6,240.00 | -2,866.00 | -4,136.00 |
| 2021-01-29 | 5,945.00 | -4,420.00 | -317.00 |
| 2020-10-30 | 5,996.00 | -3,448.00 | -192.00 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-07-25 | |||
| 2025-04-25 | |||
| 2025-01-24 | |||
| 2024-10-25 | |||
| 2024-07-26 | |||
| 2024-04-26 | |||
| 2024-01-26 | |||
| 2023-10-27 | |||
| 2023-07-28 | |||
| 2023-04-28 | |||
| 2023-01-27 | |||
| 2022-10-28 | |||
| 2022-07-29 | |||
| 2022-04-29 | |||
| 2022-01-28 | |||
| 2021-10-29 | |||
| 2021-07-30 | |||
| 2021-04-30 | |||
| 2021-01-29 | |||
| 2020-10-30 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-07-25 | ||
| 2025-04-25 | ||
| 2025-01-24 | ||
| 2024-10-25 | ||
| 2024-07-26 | ||
| 2024-04-26 | ||
| 2024-01-26 | ||
| 2023-10-27 | ||
| 2023-07-28 | ||
| 2023-04-28 | ||
| 2023-01-27 | ||
| 2022-10-28 | ||
| 2022-07-29 | ||
| 2022-04-29 | ||
| 2022-01-28 | ||
| 2021-10-29 | ||
| 2021-07-30 | ||
| 2021-04-30 | ||
| 2021-01-29 | ||
| 2020-10-30 |
Management Effectiveness
- The roa for Medtronic plc as of 25 July 2025 is 0.05.
- The roe for Medtronic plc as of 25 July 2025 is 0.09.
- The roic for Medtronic plc as of 25 July 2025 is 0.06.
- The croic for Medtronic plc as of 25 July 2025 is 0.01.
- The ocroic for Medtronic plc as of 25 July 2025 is 0.09.
| Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
| 2025-07-25 | 0.05 | 0.09 | 0.06 | 0.01 | 0.09 |
| 2025-04-25 | 0.05 | 0.09 | 0.05 | -0.00 | 0.09 |
| 2025-01-24 | 0.05 | 0.08 | 0.05 | 0.00 | 0.09 |
| 2024-10-25 | 0.04 | 0.08 | 0.05 | -0.00 | 0.09 |
| 2024-07-26 | 0.04 | 0.08 | 0.05 | -0.00 | 0.09 |
| 2024-04-26 | 0.04 | 0.07 | 0.05 | -0.04 | 0.08 |
| 2024-01-26 | 0.05 | 0.08 | 0.05 | -0.04 | 0.08 |
| 2023-10-27 | 0.05 | 0.08 | 0.05 | -0.05 | 0.07 |
| 2023-07-28 | 0.04 | 0.07 | 0.05 | -0.01 | 0.08 |
| 2023-04-28 | 0.04 | 0.07 | 0.05 | -0.03 | 0.08 |
| 2023-01-27 | 0.04 | 0.08 | 0.05 | 0.01 | 0.07 |
| 2022-10-28 | 0.05 | 0.08 | 0.05 | 0.02 | 0.08 |
| 2022-07-29 | 0.06 | 0.10 | 0.07 | -0.01 | 0.09 |
| 2022-04-29 | 0.05 | 0.10 | 0.06 | 0.00 | 0.09 |
| 2022-01-28 | 0.05 | 0.10 | 0.06 | -0.02 | 0.09 |
| 2021-10-29 | 0.05 | 0.09 | 0.06 | -0.05 | 0.09 |
| 2021-07-30 | 0.04 | 0.08 | 0.05 | -0.04 | 0.09 |
| 2021-04-30 | 0.04 | 0.07 | 0.05 | -0.01 | 0.08 |
| 2021-01-29 | 0.03 | 0.06 | 0.04 | 0.02 | 0.07 |
| 2020-10-30 | 0.04 | 0.07 | 0.04 | 0.03 | 0.07 |
Gross Margins
- The gross margin for Medtronic plc as of 25 July 2025 is 0.66.
- The net margin for Medtronic plc as of 25 July 2025 is 0.14.
- The operating margin for Medtronic plc as of 25 July 2025 is 0.20.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
| Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
| 2025-07-25 | 0.66 | 0.14 | 0.20 |
| 2025-04-25 | 0.66 | 0.13 | 0.21 |
| 2025-01-24 | 0.65 | 0.13 | 0.20 |
| 2024-10-25 | 0.66 | 0.12 | 0.20 |
| 2024-07-26 | 0.66 | 0.11 | 0.20 |
| 2024-04-26 | 0.66 | 0.13 | 0.20 |
| 2024-01-26 | 0.66 | 0.13 | 0.20 |
| 2023-10-27 | 0.66 | 0.13 | 0.19 |
| 2023-07-28 | 0.66 | 0.11 | 0.19 |
| 2023-04-28 | 0.66 | 0.12 | 0.21 |
| 2023-01-27 | 0.67 | 0.13 | 0.21 |
| 2022-10-28 | 0.68 | 0.14 | 0.22 |
| 2022-07-29 | 0.68 | 0.17 | 0.20 |
| 2022-04-29 | 0.69 | 0.16 | 0.22 |
| 2022-01-28 | 0.68 | 0.15 | 0.23 |
| 2021-10-29 | 0.68 | 0.15 | 0.23 |
| 2021-07-30 | 0.67 | 0.12 | 0.21 |
| 2021-04-30 | 0.66 | 0.12 | 0.18 |
| 2021-01-29 | 0.64 | 0.10 | 0.14 |
| 2020-10-30 | 0.65 | 0.13 | 0.15 |
Identifiers and Descriptors
| Central Index Key (CIK) | 1613103 |
Industry Groups
| SIC 3845 - Electromedical and Electrotherapeutic Apparatus |
